Oman witnesses first successful Pre-implantation Genetic Diagnosis (PGD)

Dr. Human Fatemi
Updated 05 January 2018
0

Oman witnesses first successful Pre-implantation Genetic Diagnosis (PGD)

Pre-implantation Genetic Diagnosis (PGD) has been instrumental in helping couples prevent the risk of having a child with genetic disorders, according to IVI Middle East Fertility Clinic. The fertility center recently reported its first two successful PGD pregnancies in Muscat. “PGD is a technique where medical experts can check the genes in an embryo before pregnancy occurs. Couples who have alterations or mutations in their genes, or who have a risk of having children with genetic disorders, benefit from this screening. PGD is the latest reproductive technological advancement in medical science and is immensely important as it gives possibility to these couples to have healthy children and reduces the burden on the family, the health care system and society as a whole,” said Prof. Dr. Human Fatemi, medical director, IVI Middle East Fertility Clinic.
IVI Middle East Fertility Clinic has made several advances in the reproductive medicine field. The clinic has recently reported two successful pregnancies in Muscat following PGD, which not only highlights the outstanding proficiency of the embryology team, but also demonstrates the adeptness of the clinical team for their sustained effort and commitment to achieving 73 percent successful pregnancy rates.
Until this year, Omani couples traveled abroad to seek PGD. However, with IVI Middle East Fertility Clinic reporting successful pregnancies following PGD, couples have not only found a new hope, but also have access to the world’s best treatment options in the region.
The procedure for PGD test is simple. It includes obtaining eggs from the mother and injecting them with the husband’s sperm. The fertilized eggs are then followed for five or six days until they become embryos, inside the IVF lab. Then a biopsy is performed from the mature embryo when cells are examined to rule out any genetic mutation / alteration. This process takes about ten days. In the meanwhile, the embryos are frozen by a process known as cryopreservation. When the results from the diagnostic process are available, normal embryos without the genetic disorder are transferred into the mother’s uterus.


Bahri strengthens market footprint in Asia-Pacific region

Khalid Al-Garawi, senior manager, Bahri Chemicals.
Updated 21 April 2019
0

Bahri strengthens market footprint in Asia-Pacific region

Saudi logistics and transportation company Bahri has announced the expansion of its market presence in the Asia-Pacific (APAC) region’s maritime industry. The stronger presence will help the company gain deeper insights into market trends as well as customer needs in chemicals and logistics sectors in Singapore and the wider APAC region.
The announcement took place at a ceremony held on April 5 at Regent Hotel in Singapore, in the presence of Abdullah Aldubaikhi, CEO of Bahri, and senior executives of the region’s oil majors, petrochemical trading companies and ship brokers.
The expansion will also enable Bahri Logistics and Bahri Chemicals, two of five business units of the company, to market their offerings, acquire new clients, serve existing clients, and channelize the communications. Bahri has plans to expand the services of its other business units to the APAC region in the future.
Bahri CEO Aldubaikhi said: “In our efforts to deliver on Bahri’s vision of connecting economies, sharing prosperity, and driving excellence in global logistics services, we have been actively pursuing the company’s ambitious long-term strategy to drive sustainable growth and expand its market footprint. As a result, we have established a solid presence regionally and globally. Our expansion in the Asia-Pacific region represents a key milestone in our journey, and with this, we have come even closer to our customers, allowing us to serve them better offering a wider range of industry services and unprecedented value.”
Over the past 41 years, Bahri has steadily expanded market presence to cement its position as a global leader in the maritime industry. The company currently has offices in Saudi Arabia, UAE, US and India, in addition to a vast network of agents across the Middle East and Africa, US, Europe, and Asia.
Bahri Chemicals is the largest owner and operator of chemical carriers in the Middle East, serving 150 ports worldwide. It owns and operates 36 chemical/product tankers with a capacity of 1.1 million DWT designed to the highest specifications, capable of carrying a wide range of chemical cargoes. The first business unit within Bahri, Bahri Logistics, is one of the top 10 breakbulk carriers in the world and operates six new state-of-the-art multipurpose vessels with 26,000 DWT each on a regular liner schedule.